Company Filing History:
1 out of 987 
1 out of 130 
1 out of 21 Years Active: 2022
Title: Tetuya Nagata: Innovator in Nucleic Acid Medicine
Introduction
Tetuya Nagata is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of nucleic acid medicine, particularly in the development of inhibitors for the expression of alpha-synuclein.
Latest Patents
Nagata holds a patent for an alpha-synuclein expression inhibitor. This invention provides a nucleic acid medicine that demonstrates a higher and more prolonged effect in inhibiting the expression of alpha-synuclein. The patent discloses an oligonucleotide or a pharmacologically acceptable salt thereof, which contains at least one nucleoside structure capable of binding to the alpha-synuclein gene. This oligonucleotide is complementary to the alpha-synuclein gene and has a length ranging from twelve to twenty bases.
Career Highlights
Throughout his career, Tetuya Nagata has worked with esteemed institutions such as Osaka University and Tokyo Medical and Dental University. His work has significantly advanced the understanding and treatment of diseases related to alpha-synuclein.
Collaborations
Nagata has collaborated with notable colleagues, including Masayuki Nakamori and Hideki Mochizuki. Their combined expertise has contributed to the success of his research and innovations.
Conclusion
Tetuya Nagata is a key figure in the field of nucleic acid medicine, with a focus on developing effective treatments for conditions associated with alpha-synuclein. His innovative work continues to impact the medical community positively.